| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 169 | 2.282 | 6.567 | 28.343 | 57.789 | 58.909 | 64.142 | 61.691 | 0 | 0 |
| Total Income - EUR | 169 | 2.282 | 6.567 | 28.345 | 93.481 | 89.160 | 93.202 | 90.770 | 28.970 | 9.830 |
| Total Expenses - EUR | 58 | 1.842 | 5.568 | 26.727 | 91.195 | 80.069 | 78.889 | 81.386 | 53.614 | 37.708 |
| Gross Profit/Loss - EUR | 111 | 440 | 999 | 1.618 | 2.286 | 9.091 | 14.313 | 9.384 | -24.644 | -27.878 |
| Net Profit/Loss - EUR | 106 | 395 | 933 | 1.334 | 1.708 | 8.502 | 13.672 | 8.767 | -24.644 | -27.878 |
| Employees | 0 | 1 | 1 | 3 | 4 | 5 | 5 | 6 | 1 | 1 |
Check the financial reports for the company - Bioproduct Invest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 212.705 | 178.403 | 245.157 | 210.330 | 181.500 | 151.557 | 122.315 |
| Current Assets | 70 | 1.019 | 39.131 | 33.908 | 58.333 | 44.580 | 20.386 | 87.547 | 9.043 | 3.541 |
| Inventories | 16 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 6.567 | 33.728 | 53.386 | 35.079 | 19.902 | 87.365 | 8.061 | 3.194 |
| Cash | 54 | 868 | 32.564 | 180 | 4.946 | 9.501 | 484 | 181 | 982 | 347 |
| Shareholders Funds | -36 | 359 | 1.286 | 2.597 | 4.255 | 12.676 | 26.067 | 8.959 | -15.713 | -43.503 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 106 | 660 | 37.845 | 244.016 | 101.449 | 178.124 | 136.860 | 221.132 | 166.431 | 169.359 |
| Income in Advance | 0 | 0 | 0 | 0 | 131.032 | 98.937 | 67.789 | 38.956 | 9.883 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1039 - 1039" | |||||||||
| CAEN Financial Year |
1039
|
|||||||||
Comments - Bioproduct Invest Srl